Cyient Shares Drop 6% After Turning Ex-Record Date for Rs 720 Crore Buyback
Cyient's stock witnessed a significant 6% decline on Wednesday as the shares turned ex-record date for its upcoming share buyback program. The price correction follows the technical transition that makes new investors ineligible for the company's massive repurchase offer.
Understanding the Buyback and the Ex-Record Date Impact
The sudden dip in Cyient’s share price is largely attributed to the stock turning "ex-record date" on June 17. For the Rs 720 crore buyback, only shareholders who held the company's stock in their demat accounts as of the record date are eligible to participate.
Due to SEBI’s T+1 settlement rule, investors purchasing shares today will only see them credited to their accounts tomorrow, rendering them ineligible to tender shares for the buyback. Cyient has announced it will repurchase up to 64 lakh shares at a price of Rs 1,125 per share. This offer represents a substantial premium of approximately 24% over the previous closing price, a move typically designed to reward long-term shareholders and utilize surplus cash.
Historical Performance and Market Context
While the buyback offers a premium, Cyient’s broader stock performance has faced considerable headwinds. The company's shares have declined by nearly 23% in 2026 so far. Looking at longer timeframes, the volatility is even more pronounced: the stock has fallen 36% over the last year and 42% over the last three years, showing only marginal gains on a five-year horizon.
With a current market capitalization of less than Rs 9,540 crore, the company is navigating a period of stabilization. This buyback marks Cyient’s first such corporate action since 2019, as the management seeks to manage shareholder value amidst fluctuating market conditions.
Analyst Outlook: Growth Headwinds vs. Future Targets
Despite the buyback, market analysts remain cautious regarding the company's immediate trajectory. Emkay has maintained a 'Reduce' call on Cyient shares, although they have marginally increased their target price from Rs 850 to Rs 900. This new target implies a downside potential of less than 1% from the recent closing price of Rs 907.65.
해당 증권사는 거시경제적 역풍으로 인해 FY26의 성장세가 둔화될 것이라고 밝혔습니다. 엔지니어링 연구 개발(ER&D) 지출은 한 자릿수 중후반대의 성장세를 보이며 견조하게 유지되고 있으나, 특정 운영상의 과제들이 나타나고 있습니다. 특히 매출 부진, 고객사별 프로그램 요구 사항, 글로벌 공급망 혼란으로 인해 DLM 재고 회전일수가 63일 증가했습니다. 하지만 경영진이 FY27에 더 강력하고 수익성 있는 성장을 달성하는 것을 목표로 하고 있다는 점은 긍정적인 요소입니다.
핵심 요약
- 자사주 매입 상세 내용: Cyient는 주당 1,125루피로 720억 루피 규모의 자사주 매입을 진행하며 24%의 프리미엄을 제공하고 있으나, 권리락일(ex-record date)로 인해 신규 매수자는 대상에서 제외됩니다.
- 주가 실적: 이 회사는 2026년에 23% 하락했으며, 지난 1년간 36% 급락하며 어려움을 겪고 있습니다.
- 애널리스트 의견: Emkay는 ER&D 지출은 견조하지만, 거시경제적 역풍과 재고 관련 과제가 FY26 성장에 영향을 미쳤다고 언급하며 '축소(Reduce)' 의견을 유지했습니다.